CAMBRIDGE, United Kingdom, January 27, 2006 - ProQuest Information and Learning is now the exclusive global distributor of Evidence Matters to academic and hospital markets. ProQuest Information and Learning, a unit of ProQuest Company, creates and publishes databases for libraries and educational institutions worldwide.

Evidence Matters is a new digital medical resource that allows clinicians to compare therapies for their patients based on peer-reviewed medical research. Evidence Matters goes beyond the information available in bibliographic databases to provide answers to clinical questions drawn from an enormous collection of statistical evidence. Evidence Matters has a simple ‘ask-a-question' interface and results are organised into summary graphs or tables, based on therapy effectiveness, safety and cost. Evidence Matters currently covers cancer, cardiology and endocrinology, and will grow to cover other medical disciplines.

“This is the most time-friendly device for medical information I've ever seen,” says Dr. George Michaels, Assistant Professor, Family Medicine McGill University, and Assistant Physician-in-Chief, St. Mary's Hospital. “I cannot believe this will not become the new standard of care.”

Evidence Matters research comes from a range of sources including MEDLINE and CINAHL (Cumulative Index to Nursing and Allied Health), as well as the Cochrane Library and renowned journals such as The New England Journal of Medicine, Journal of Clinical Oncology, Journal of the American Medical Association, British Medical Journal, and The Lancet.

The distribution agreement with Evidence Matters builds further ProQuest's family of health sciences information products. “Evidence Matters is an ideal solution to help satisfy the increasing demand for evidence-based medical information,” said Roger Tritton, ProQuest Senior Publisher. “Evidence Matters is an exciting complement to ProQuest's own periodical full-text products and the medical books distributed on the MyiLibrary platform.”

Evidence Matters is an award-winning, venture backed company. MedTech Partners, originally formed by the Canadian Medical Discovery Fund and MDS Capital, is one of Canada 's leading seed investors and is the main investor in Evidence Matters.

If you would like further product information please e-mail marketing@proquest.co.uk

About ProQuest
ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning. A global leader in serving libraries of all types, ProQuest offers the expertise of such respected brands as Chadwyck-Healey™, UMI®, SIRS®, and eLibrary®. With Serials Solutions®, Ulrich's™, RefWorks®, COS™, Dialog® and now Bowker® part of the ProQuest brand family, the company supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience.

More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others. Inspired by its customers and their end users, ProQuest is working toward a future that blends information accessibility with community to further enhance learning and encourage lifelong enrichment.

For more information, visit www.proquest.com or the ProQuest parent company website, www.cig.com.